MedicarePartD.guide

A non-government resource built from CMS public data

Tremfya on BlueRx Essential (S1030-006)

guselkumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 12 per 180 days.

$3,760.72
Patient pays / month, after deductible
$4,221.97
Patient pays / month, before the $615.00 deductible
$11,282.15
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

TREMFYA 200 mg/2mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $15,042.86 for a month. Other covered strengths are listed below.

Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
FormTierPatient pays / monthLimits
TREMFYA 100 mg/mL Injection5$7,072.69PA · 3 per 56 days
TREMFYA 100 mg/mL Injection5$7,041.82PA · 3 per 56 days
TREMFYA 200 mg/2mL Injection5$3,764.16PA · 2 per 28 days
TREMFYA 200 mg/2mL Injection5$3,760.72PA · 12 per 180 days
TREMFYA 200 mg/2mL Injection5$3,763.73PA · 2 per 28 days

Other IL-17 and IL-23 biologics on this plan

Verify with the plan before prescribing or filling. Member services: (800)327-3998. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s1030-006